• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

CR question


  • Please log in to reply
6 replies to this topic

#1 John Schloendorn

  • Guest, Advisor, Guardian
  • 2,542 posts
  • 157
  • Location:Mountain View, CA

Posted 24 May 2005 - 05:22 AM


Background (without literature backup -- please correct me where I'm wrong):
Caloric restriction (CR) at adult onset extends healthy life span in most animal models tested. We're still waiting for that result in humans, and we will be for a while. In some of these species, a consistent pattern of gene expression changes that occurs relatively soon after CR onset is well documented. (For a list of those changes see e.g. the intro of Berner et al 2004).

Is it time to investigate corresponding changes in tissue samples from live human CR volunteers? If yes, has any of it been done? If yes, what was found?

#2 wraith

  • Guest
  • 182 posts
  • 0

Posted 24 May 2005 - 08:29 PM

Seems like a good idea. I'll wait and see if anyone who actually knows something has a response.
~
Thanks for the link to the article, it looks interesting; I hope I can get a copy.

Click HERE to rent this GENETICS advertising spot to support LongeCity (this will replace the google ad above).

#3 Michael

  • Advisor, Moderator
  • 1,293 posts
  • 1,792
  • Location:Location Location

Posted 26 May 2005 - 05:37 PM

All:

John Schloendorn: Background (without literature backup -- please correct me where I'm wrong): Caloric restriction (CR) at adult onset extends healthy life span in most animal models tested.


Importantly, the only real example of which I can think of a failure was the housefly. It workds pretty darned consistently in vertebrates and, in particular, mammals. The results in cattle are rather crude, however, and we're still waiting for maximum lifespan results in nonhuman primates.

John Schloendorn: In some of these species, a consistent pattern of gene expression changes that occurs relatively soon after CR onset is well documented. (For a list of those changes see e.g. the intro of Berner et al 2004). Is it time to investigate corresponding changes in tissue samples from live human CR volunteers? If yes, has any of it been done? If yes, what was found?


It has not been done yet. The NIA's multi-site CALERIE study, the substudy (1) out of Washington University School of Medicine of members of long-term CR folk drawn from the CR Society, and the Society's own CR Society Cohort Study are all for the moment just doing the obvious, relatively noninvasive stuff: lipids, glycemia, cardiac stress tests, bracial artery responsiveness, etc. However, CALERIE is going to eventually do muscle and adipose biopsies for gene expression studies:

CALERIE Study Grant Cover:
Hypothesis D. Chronic CR is associated with adaptations in the expression of genes involved in aging, including those related to oxidative stress, energy metabolism (carbohydrate, lipid and protein), and longevity.
Aim D: Measure for differences in the expression of candidate genes in skeletal muscle and adipose tissue.


But you ask, "Is it time to investigate corresponding changes in tissue samples from live human CR volunteers?" and I'm not sure that the answer should be any more than a lukewarm "Sure." Such a study would primarily be of interest to see if the effects of CR at the gene expression profile level would parallel those observed in CR rodents, adding to the case that CR will indeed retard aging in humans. This data would be useful for one of two purposes: to get people to practice CR, or to further the development of CR mimetics (Spindler's company, Biomarker Pharmaceuticals, is pursuing this.

Now, on the former: I don't know that gene expression studies would add all THAT much incentive to individual humans taking up CR beyond what's already out there (eg, (1-11)) to show that CR in normal-weight persons reduces disease risk and appears to be effective as an anti-aging intervention. The connection between reduced heat shock protein expression or differential regulation of TCA cycle enzymes and an actual health outcome is rather murkier than the effects on risk factors and I suspect major hormones to the average person (although LEF's nonsensical claims about "Reversing Aging Rapidly With Short-Term Calorie Restriction" (along with the related editorials and news stories), and the equally misleading followup on a later study, "BioMarker Pharmaceuticals Develops Anti-Aging Therapy", may have the beneficial side-effect of making their readership take such data more seriously, although for the wrong reasons).

On the other hand, they might well lead to the facilitation of the development of CR mimetics -- but as I've argued elsewhere (12-14), that's a distraction from the real work of developing more effective, real anti-aging medicine via SENS -- and potentially a widely fatal one, as (a) the tiny pool of resources devoted to developing anti-aging interventions are, at present, almost entirely going that way, and could instead be going to SENS, and (b) for regulatory and scientific reasons, it will likely take much longer (by decades) to develop and document the efficacy of CR mimetics than age-reversing technologies.

-Michael

1. Fontana L, Meyer TE, Klein S, Holloszy JO.
Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans.
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6659-63. Epub 2004 Apr 19.
PMID: 15096581 [PubMed - indexed for MEDLINE]

2. Walford RL, Mock D, Verdery R, MacCallum T. Calorie restriction in
Biosphere 2: alterations in physiologic, hematologic, hormonal, and
biochemical parameters in humans restricted for a 2-year period. J
Gerontol A Biol Sci Med Sci. 2002 Jun;57(6):B211-24.

3. Velthuis-te Wierik EJ, van den Berg H, Schaafsma G, Hendriks HF,
Brouwer A. Energy restriction, a useful intervention to retard human
ageing? Results of a feasibility study. Eur J Clin Nutr. 1994
Feb;48(2):138-48.

4. Vallejo EA. La dieta de hambre a dias alternos in la alimentacion de
los viejos. [A fasting diet on alternate days in the feeding of the
elderly]. Rev Clin Esp. 1957 Oct 15;63(1):25–7. Spanish.

5. Kagawa Y. Impact of Westernization on the nutrition of Japanese:
changes in physique, cancer, longevity and centenarians. Prev Med. 1978
Jun;7(2):205-17.

6. Suzuki M, Wilcox BJ, Wilcox CD. Implications from and for food
cultures for cardiovascular disease: longevity. Asia Pac J Clin Nutr.
2001;10(2):165-71.

7. Willcox BJ, Willcox DC, Suzuki M. The Okinawa Program: How the
World's Longest-Lived People Achieve Everlasting Health – and How You
Can Too. 2001; New York: Crown Publishers.

7a. Willcox BJ, Willcox DC, Suzuki M. The Okinawa Diet Plan: Get Leaner,
Live Longer, and Never Feel Hungry. 2004; New York: Clarkson Potter,
23-4 and citations.

8. Todoriki H, Willcox DC, Willcox BJ. The effects of post-war dietary
change on longevity and health in Okinawa. Okinawan J Am Stud.
2004;1:55-64. And personal communication, BJ Willcox.

9. Akisaka M, Asato L, Chan YC, Suzuki M, Uezato T, Yamamoto S. Energy
and nutrient intakes of Okinawan centenarians. J Nutr Sci Vitaminol
(Tokyo). 1996 Jun;42(3):241-8.

10. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC.
Calorie restriction, aging, and cancer prevention: mechanisms of action
and applicability to humans. Annu Rev Med. 2003;54:131-52. Includes good
review of results of cancer studies in European famine cohorts.

11. Heilbronn LK, Ravussin E. Calorie restriction and aging: review of
the literature and implications for studies in humans. Am J Clin Nutr.
2003 Sep;78(3):361-9.

12. Rae M.
It's never too late: calorie restriction is effective in older mammals.
Rejuvenation Res. 2004 Spring;7(1):3-8. Review. No abstract available.
PMID: 15256039 [PubMed - indexed for MEDLINE]

13. Rae MJ.
Anti-Aging Medicine: Fallacies, Realities, and Imperatives.
J Gerontol A Biol Sci Med Sci. 2005; in press.

14. Rae MJ.
You Don’t Need a Weatherman: Famines, Evolution, and Intervention into Aging.
Gerontology. Submitted.

#4 John Schloendorn

  • Topic Starter
  • Guest, Advisor, Guardian
  • 2,542 posts
  • 157
  • Location:Mountain View, CA

Posted 27 May 2005 - 06:48 AM

Thanks Michael! I'm familiar with your published paper. I completely agree with your pro-SENS argument. Keep up the good work!
The issue I'm having with the disease phenotype studies is that they can't control for all the variance from other sources. I'd suspect that CR people are much more health concerned in every respect, i.e. have regular check-ups, exercise, working environment, living conditions, ect. and thus better health. People aren't lab mice, basically. This is what I think a gene expression study on what are considered unique markers of CR could provide.
Although the anti-atherosclerosis effect in particular was quite strong and probably points in the right direction.

#5 qu2119

  • Guest
  • 1 posts
  • 0

Posted 17 June 2005 - 12:23 AM

Hi, Michael,

If you have time, please evaluate this paper about CR.

Fu, C., Xi, L., Wu, Y., McCarter, R., Richardson, A., Hickey, M., and Han, E-S. Hepatic genes altered in expression by food restriction
are not influenced by the low plasma glucose level in young male GLUT4 transgenic Mice. Journal of Nutrition 2004; 134: 2965–74.

Thank you,

Jason

#6 Michael

  • Advisor, Moderator
  • 1,293 posts
  • 1,792
  • Location:Location Location

Posted 24 June 2005 - 02:45 AM

All:

If you have time, please evaluate this paper about CR.

Fu, C., Xi, L., Wu, Y., McCarter, R., Richardson, A., Hickey, M., and Han, E-S. Hepatic genes altered in  expression by food restriction
are not influenced by the low plasma glucose level in young male GLUT4 transgenic Mice. Journal of Nutrition 2004; 134: 2965–74.


See this thread, especially Prometheus' comments; this really is surprising, because even if insulin signaling per se is unaltered in these mice, one would still expect some effect on lifespan via glycation, if nothing else.

Gene chip studies should, in general, be interpreted with extreme caution, as the tools haven't been properly validated and results of analyses using different tools are not consistent with one another. (1)

IAC, as I said, it doesn't matter, because (a) these studies do not add to our ability to determine whether CR is really extrapolable to humans, and (b) the development of CR mimetics is a wrongheaded approach to anti-aging medicine. The path ahead is clear (2,3), irrespective of how CR works.

-Michael

1: Marshall E.
Getting the noise out of gene arrays.
Science. 2004 Oct 22;306(5696):630-1. No abstract available.
PMID: 15499004 [PubMed - indexed for MEDLINE]

2. de Grey AD, Ames BN, Andersen JK, Bartke A, Campisi J, Heward CB, McCarter RJ, Stock G.
Time to talk SENS: critiquing the immutability of human aging.
Ann N Y Acad Sci. 2002 Apr;959:452-62; discussion 463-5.
PMID: 11976218 [PubMed - indexed for MEDLINE]
http://www.gen.cam.a...sens/manu12.pdf

3. de Grey AD. An engineer's approach to the development of real anti-aging medicine. Sci Aging Knowledge Environ. 2003 Jan 8;2003(1):VP1. Review. PMID: 12844502 [PubMed - indexed for MEDLINE]
http://www.gen.cam.a...sens/manu16.pdf

Click HERE to rent this GENETICS advertising spot to support LongeCity (this will replace the google ad above).

#7 Mind

  • Life Member, Director, Moderator, Treasurer
  • 19,068 posts
  • 2,000
  • Location:Wausau, WI

Posted 25 May 2009 - 09:09 PM

I was looking for a past discussion about gene expression and CR and this is the best one I could come up with. If anyone else knows of a better discussion, feel free to suggest. This is a nematode study.

HIF-1 protein might play key role in longevity through dietary restriction. (nice visuals and graphs)

Eureka Alert covering the same.

A protein that plays a key role in tumor formation, oxygen metabolism and inflammation is involved in a pathway that extends lifespan by dietary restriction. The finding, which appears in the May 22, 2009 edition of the on-line journal PLoS Genetics, provides a new understanding of how dietary restriction contributes to longevity and cancer prevention and gives scientists new targets for developing and testing drugs that could extend the healthy years of life.

The protein is HIF-1 (hypoxia-inducible factor 1). It helps cells survive by "turning on" when oxygen levels are low. HIF-1 is also active in some forms of human cancer. HIF-1 overexpression is frequently detected in solid tumors; inhibition of HIF-1 has been proved to be an efficient way to prevent cancer growth. Now, scientists at the Buck Institute for Age Research have shown that HIF-1 is also a key player in dietary restriction. HIF-1 is involved in a molecular pathway known to regulate cell growth and metabolism in response to nutrients and growth factors.

"Previous studies on HIF-1 have mainly focused on its roles in oxygen metabolism and tumor development", said Buck faculty member Pankaj Kapahi, PhD, lead author of the study.

Kapahi says the study encourages the investigation of HIF-1 in nutrient sensing pathways. "The data in this study also points to HIF-1 as a likely target for regulating the protective effects of dietary restriction in mammals," said Kapahi.






1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users